MDB is trading at $254.99 (-22.37%) following its Q4 fiscal 2026 earnings release as investors weigh strong quarterly results against concerns over future guidance.
- Revenue hit $695.1 million, up 27% year-over-year, with Atlas growth reaching 29% and non-GAAP EPS at $1.65.
- Despite beating estimates, the stock fell sharply due to incomplete guidance details and high market expectations.